Clinical Trials List
Protocol Number20180290
2021-04-01 - 2024-03-15
Phase I
Recruiting2
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Shao-Jung Hsu Division of General Internal Medicine
- Rheun-Chuan Lee Division of Radiology
- Yun-Cheng Hsieh Division of General Internal Medicine
- 姜乃榕 Division of Hematology & Oncology
- Chung-Pin Li Division of Hematology & Oncology
- San-Chi Chen Division of Hematology & Oncology
- Chien-An Liu Division of Radiology
- Yee Chao Division of Hematology & Oncology
- Yi-Ping Hung Division of Hematology & Oncology
- Hao-Wei Teng Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chiun Hsu Division of Hematology & Oncology
- Chih-Hung Hsu Division of Hematology & Oncology
- 陳國興 Division of Hematology & Oncology
- Kun-Huei Yeh Division of Hematology & Oncology
- Hsiang-Fong Kao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
150 participants
